Ekaterine Metreveli in Feasterville Trevose, Pennsylvania

Home Pennsylvania Feasterville Trevose

Ekaterine Metreveli has Nurse Practitioner as her primary medical specialty. Their primary office is: 1200 Bustleton Pike in Feasterville Trevose, Pennsylvania. They attended Sorry, her university is not listed and graduated in 2016 (around 8 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Ekaterine Metreveli Office Phone and Directions

Ekaterine Metreveli
1200 Bustleton Pike
Feasterville Trevose, Pennsylvania 19053
267-574-5236

Patient Ratings
Please rate your experience with Ekaterine Metreveli below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 267-574-5236

Enter a starting address:

Healthcare Info for Ekaterine Metreveli

Medical School: Sorry, her university is not listed
Graduation Year: 2016
The Primary Medical Specialty for Ekaterine Metreveli is listed as: Nurse Practitioner
Approximate Years of Experience: 8
PAC (PECOS ID)#: 8820364243
NPI #: 1073052189
NPI Created On: 02/22/2017
NPI Last Updated Listed as: 08/08/2019
Primary Taxonomy Code: 363LA2200X
License Number:
SP017126
Listed Gender: Female

Accepted forms of Insurance

Forms of insurance accepted by include, but are not limited to:

AmeriHealth New Jersey
Blue Cross Blue Shield
Highmark Health Insurance Company
Highmark Inc.
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: Georgian, English.

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794931419

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: NEUROSCIENCE

Name of Drug #1: UBRELVY

Open Associated Drug #1: 0023-6501-10